scispace - formally typeset
A

Anthony K.C. Chan

Researcher at McMaster Children's Hospital

Publications -  405
Citations -  17396

Anthony K.C. Chan is an academic researcher from McMaster Children's Hospital. The author has contributed to research in topics: Antithrombin & Heparin. The author has an hindex of 64, co-authored 373 publications receiving 15370 citations. Previous affiliations of Anthony K.C. Chan include Hamilton Health Sciences & McMaster University.

Papers
More filters
Journal ArticleDOI

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

TL;DR: The evidence supporting most recommendations for antithrombotic therapy in neonates and children remains weak and Studies addressing appropriate drug target ranges and monitoring requirements are urgently required in addition to site- and clinical situation-specific thrombosis management strategies.
Journal ArticleDOI

Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

TL;DR: Within this chapter, the majority of recommendations are separate for neonates and children, reflecting the significant differences in epidemiology of thrombosis and safety and efficacy of therapy in these two populations.
Journal ArticleDOI

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

TL;DR: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program has proven to be a significant resource in US neuroendocrine tumor (NET) epidemiology.
Journal ArticleDOI

Bronchopulmonary neuroendocrine tumors

TL;DR: A broad overview of Bronchopulmonary neuroendocrine tumors is provided and focuses on the evolution of the disease, general features, and current diagnostic and therapeutic options.
Journal ArticleDOI

Developmental haemostasis : Impact for clinical haemostasis laboratories

TL;DR: The results confirm the need for coagulation laboratories to develop age-related reference ranges specific to their own testing systems and confirm that accurate diagnosis and management of neonates and children with suspected bleeding or clotting disorders is not possible.